Stock Quote Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Markets Stocks ETFs Tools Overview News Currencies International Treasuries Albireo Pharma Inc (NQ: ALBO ) 44.15 UNCHANGED Last Price Updated: 4:00 PM EST, Mar 2, 2023 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 0 Open 44.15 Bid (Size) 44.10 (10) Ask (Size) 44.30 (13) Prev. Close 44.15 Today's Range 44.15 - 44.15 52wk Range 16.02 - 45.23 Shares Outstanding 20,701,283 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Analyst Ratings for Albireo Pharma February 15, 2023 Via Benzinga ALBIREO PHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Albireo Pharma, Inc. - ALBO January 24, 2023 From Kahn Swick & Foti, LLC Via Business Wire Performance YTD +106.60% +106.60% 1 Month N/A N/A 3 Month -0.52% -0.52% 6 Month +100.96% +100.96% 1 Year +121.53% +121.53% More News Read More BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Paya Holdings Inc. (Nasdaq – PAYA), CinCor Pharma, Inc. (Nasdaq – CINC), Albireo (Nasdaq – ALBO), Duck Creek Technologies (Nasdaq - DCT) January 20, 2023 From Brodsky & Smith LLC Via GlobeNewswire Cowen & Co. Downgrades Albireo Pharma: Here's What You Need To Know January 11, 2023 Via Benzinga Expert Ratings for Albireo Pharma January 11, 2023 Via Benzinga Looking Into Albireo Pharma's Return On Capital Employed December 05, 2022 Via Benzinga Why These Two Biotech Stocks Blasted Higher This Week January 13, 2023 Via The Motley Fool Benzinga's Top Ratings Upgrades, Downgrades For January 11, 2023 January 11, 2023 Via Benzinga ALBIREO PHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Albireo Pharma, Inc. - ALBO January 10, 2023 From Kahn Swick & Foti, LLC Via Business Wire BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Paya Holdings Inc. (Nasdaq – PAYA), CinCor Pharma, Inc. (Nasdaq – CINC), Albireo (Nasdaq – ALBO), Duck Creek Technologies (Nasdaq - DCT) January 10, 2023 From Brodsky & Smith LLC Via GlobeNewswire S&P 500 Gains 0.6%; Albireo Pharma Shares Spike Higher January 09, 2023 Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For January 10, 2023 January 10, 2023 Via Benzinga Why Cutera Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Monday's Mid-Day Session January 09, 2023 Via Benzinga 12 Health Care Stocks Moving In Monday's Intraday Session January 09, 2023 Via Benzinga Nasdaq Surges Over 200 Points; Crude Oil Rises 2% January 09, 2023 Via Benzinga 2 Tiny Nasdaq Stocks Making Major Merger Moves Monday January 09, 2023 Via The Motley Fool Tesla, Zillow, Albireo Pharma And Some Other Big Stocks Moving Higher On Monday January 09, 2023 Via Benzinga US Stocks Open Higher; Dow Rises 150 Points January 09, 2023 Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For January 9, 2023 January 09, 2023 Via Benzinga ALBO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Albireo Pharma, Inc. Is Fair to Shareholders January 09, 2023 From Halper Sadeh LLC Via Business Wire 12 Health Care Stocks Moving In Monday's Pre-Market Session January 09, 2023 Via Benzinga Why CinCor Pharma Shares Are Trading Higher By 140%; Here Are 20 Stocks Moving Premarket January 09, 2023 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday January 09, 2023 Via InvestorPlace France-Based Ipsen Acquires Albireo Pharma Enriching Its Rare Disease Portfolio, Pipeline January 09, 2023 Via Benzinga Have A Look At William Blair's Top Biotech Picks For 2023 December 25, 2022 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
